A new combination drug therapy could help people with inflammatory bowel disease (IBD) for whom other medicines have stopped ...
For patients with Crohn's disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy ...
Tuberculosis infected more than 8 million people in 2024 -- surpassing COVID-19 and marking a record high since 1995 -- as a ...
Scientists from A*STAR Infectious Diseases Labs (A*STAR IDL), Nanyang Technological University, Singapore's Lee Kong Chian ...
Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic benefit for patients with severe forms of treatment-resistant autoimmune ...
New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...
No, it’s not a fever dream. A deadly disease that toppled ancient civilizations is becoming increasingly resistant to antibiotics, posing a significant threat in certain parts of the world. “Despite ...
FDA approval covers ER-positive/HER2-negative metastatic disease with ESR1 mutations after ≥1 endocrine line, with ...
Prevention of drug-resistant tuberculosis is a global health priority. However, trials evaluating the effectiveness of treating Mycobacterium tuberculosis infection among contacts of persons with drug ...
Here's a look at how to prevent drug-resistant shigella, a type of bacteria that causes shigellosis, a diarrheal infection.
Around the world, infections are becoming harder to treat. This problem is known as antimicrobial resistance. It happens when ...
Bronchoscopy-based lower airway sequencing showed higher resistome abundance and diversity in COPD, bronchiectasis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results